Vinci Compass buys control of medical-education platform Sanar

What's the deal? Vinci Compass has agreed to acquire a controlling stake in SanarDealroom has a profile for this one. Try Dealroom →, a Brazilian medical-education platform, through its Vinci Capital Partners IV fund. The all-secondary deal, announced in November, gives full exits to six venture backers — DNA CapitalDealroom has a profile for this one. Try Dealroom →, Valor Capital Group, Vox CapitalDealroom has a profile for this one. Try Dealroom →, Igah VenturesDealroom has a profile for this one. Try Dealroom →, PenínsulaDealroom has a profile for this one. Try Dealroom →, and Green RockDealroom has a profile for this one. Try Dealroom →. Terms were not disclosed.

What does Sanar do? Founded as an exam-prep course, Sanar now trains physicians from undergraduate study through high-complexity specialisation across four business units. It serves about 50,000 physicians and projects roughly US$64M in 2026 revenue.

What changes? Founders Ubiraci Mercês, Caio Nunes, and Maurício Lima stay on as partners and continue running the company. The deal is Vinci Capital Partners IV's fourth investment; the US$1.02B fund has also backed IT-rental firm ArklokDealroom has a profile for this one. Try Dealroom →, restaurant chain OutbackDealroom has a profile for this one. Try Dealroom →, and logistics company AGVDealroom has a profile for this one. Try Dealroom →.

Why Sanar? "This is a sector we like a lot and that has very relevant long-term growth," said Vinci Compass partner Carlos Eduardo Martins (translated from Portuguese), pointing to the rise in medical undergraduate programmes in recent years. Sanar is profitable and plans to expand into more specialties and new regions using an asset-light model.

The signal: The deal lands amid a wave of consolidation in Brazilian medical education, where AfyaDealroom has a profile for this one. Try Dealroom → and YduqsDealroom has a profile for this one. Try Dealroom → recently agreed to combine into a roughly US$2.3B group and Mubadala-backed Clariens has expanded through acquisitions. Unlike those institutional platforms, Sanar spans the full physician-training funnel — a private-equity bet on a specialised, profitable business rather than a distressed sale or a cash injection.

Read more: lavca.org

Image credit: US Army Africa